Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Frederick R Appelbaum

8PUBLICATIONS

39CO-AUTHORS

Medical infection agents (incl. prions)Litigation, adjudication and dispute resolutionHaematologyHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (8)

Sort by Publication Date:

|Nov 24, 2025

Prognostic impact of age and MDS-associated mutations in <i>NPM1</i> -mutated AML.

Vivian M Liu, Megan Othus, Jasmine Naru

|Jan 27, 2025

Probability of remission with reinduction with 7+3 versus high-dose cytarabine: analysis of SWOG trial S1203.

Megan Othus, Guillermo Garcia-Manero, Frederick R Appelbaum

|Dec 12, 2024

Relationship between donor source, pre-transplant measurable residual disease, and outcome after allografting for adults with acute myeloid leukemia.

Corentin Orvain, Filippo Milano, Eduardo Rodríguez-Arbolí

|Oct 09, 2024

Offering patients a second chance: what is the minimum cure rate needed to justify allogeneic hematopoietic cell transplantation?

Frederick R Appelbaum

|Mar 03, 2021

Midostaurin reduces relapse in FLT3-mutant acute myeloid leukemia: the Alliance CALGB 10603/RATIFY trial.

Richard A Larson, Sumithra J Mandrekar, Lucas J Huebner

|May 26, 2018

Next-generation sequencing for measuring minimal residual disease in AML.

Roland B Walter, Frederick R Appelbaum

Pageof 2

Frequent Collaborators

3 joint publications

Megan Othus

2 joint publications

Suravi Raychaudhuri

2 joint publications

Eliana Dietrich

2 joint publications

Brenda M Sandmaier

2 joint publications

Roland B Walter

1 joint publications

Paul J Martin

1 joint publications

Rainer F Storb

1 joint publications

Richard T Maziarz

1 joint publications

H Joachim Deeg

1 joint publications

Stephanie J Lee

Frequent Collaborators

3 joint publications

Megan Othus

2 joint publications

Suravi Raychaudhuri

2 joint publications

Eliana Dietrich

2 joint publications

Brenda M Sandmaier

Top Related Videos

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on : Sep 20, 2016

Establishing 3-Dimensional Spheroids from Patient-Derived Tumor Samples and Evaluating their Sensitivity to Drugs

Establishing 3-Dimensional Spheroids from Patient-Derived Tumor Samples and Evaluating their Sensitivity to Drugs

Published on : Dec 16, 2022

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Published on : Mar 05, 2018

See more related videos

Top Related Videos

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on : Sep 20, 2016

Establishing 3-Dimensional Spheroids from Patient-Derived Tumor Samples and Evaluating their Sensitivity to Drugs

Establishing 3-Dimensional Spheroids from Patient-Derived Tumor Samples and Evaluating their Sensitivity to Drugs

Published on : Dec 16, 2022

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Published on : Mar 05, 2018

See more related videos